These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9583460

  • 1. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
    Naitoh N, Washizuka T, Takahashi K, Aizawa Y.
    Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460
    [Abstract] [Full Text] [Related]

  • 2. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y, Chinushi M, Naitoh N, Shibata A.
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [Abstract] [Full Text] [Related]

  • 3. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
    Aizawa Y, Naitoh N, Washizuka T, Kitazawa H, Takahashi K, Kodama I, Shibata A.
    Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN.
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [Abstract] [Full Text] [Related]

  • 5. Action of antiarrhythmic agents on the area of slow conduction in ventricular tachycardia.
    Aizawa Y, Chinushi M, Abe A, Ohhira K, Shiba M, Fujita S.
    Jpn Heart J; 1996 Sep; 37(5):773-84. PubMed ID: 8973389
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS, Pierangeli A.
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of electrophysiologic effects of intravenous E-4031 and MS-551, novel class III antiarrhythmic agents, in patients with ventricular tachyarrhythmias.
    Naitoh N, Tagawa M, Yamaura M, Taneda K, Furushima H, Aizawa Y.
    Jpn Heart J; 1998 Jul; 39(4):457-67. PubMed ID: 9810296
    [Abstract] [Full Text] [Related]

  • 12. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
    Aizawa Y, Chinushi M, Kitazawa H, Washizuka T, Abe A, Shibata A, Kodama I.
    Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
    [Abstract] [Full Text] [Related]

  • 13. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
    Kidwell GA, Greenspon AJ, Greenberg RM, Volosin KJ.
    Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effect of amiodarone on pacing induced terminability of reentrant ventricular tachycardia.
    Chinushi M, Uchiyama H, Nakagawa I, Washizuka T, Aizawa Y.
    Jpn Heart J; 1999 Jul; 40(4):471-5. PubMed ID: 10611912
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

  • 16. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
    Kus T, Costi P, Dubuc M, Shenasa M.
    Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
    [Abstract] [Full Text] [Related]

  • 17. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
    Long B, Koyfman A.
    J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects of intravenous MS-551, a novel class III antiarrhythmic agent, on human atrium and ventricle.
    Naitoh N, Taneda K, Tagawa M, Furushima H, Yamaura M, Aizawa Y.
    Jpn Heart J; 1998 May; 39(3):297-305. PubMed ID: 9711181
    [Abstract] [Full Text] [Related]

  • 19. The use of the block cycle length as a safe and efficient means of interrupting sustained ventricular tachycardia and its pharmacological modification.
    Ohira K, Niwano S, Furushima H, Taneda K, Chinushi M, Aizawa Y.
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1686-92. PubMed ID: 9744429
    [Abstract] [Full Text] [Related]

  • 20. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
    Marchlinski FE, Buxton AE, Kindwall KE, Miller JM, Rosenthal ME, Gottlieb CD, Bloom RB, Josephson ME.
    Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.